Related Experiment Video

Updated: Aug 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Insulin in the early management of diabetic complications

John M Miles1

  • 1Mayo Medical School, Rochester, Minnesota, USA.

The Journal of the Association of Physicians of India
|September 17, 2003
PubMed

Insights

Improved glycemic control benefits type 1 diabetes microvascular health. For type 2 diabetes, managing insulin resistance factors like blood pressure and lipids is key for reducing cardiovascular risks.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Glycemic control is crucial for reducing microvascular complications in both type 1 and type 2 diabetes.
  • Macrovascular complications are more prevalent in type 2 diabetes, with less clear benefits from tight glycemic control.
  • Addressing insulin resistance through blood pressure and lipid management significantly impacts cardiovascular outcomes in type 2 diabetes.

Purpose of the Study:

  • To review the impact of diabetes pharmacotherapy on cardiovascular outcomes.
  • To compare the effects of insulin therapy versus sulfonylureas on endothelial function and lipids.

Main Methods:

  • Literature review and analysis of existing studies on diabetes pharmacotherapy and cardiovascular outcomes.
  • Comparative analysis of insulin therapy and sulfonylureas regarding endothelial function and lipid profiles.

Main Results:

  • Improved glycemic control effectively reduces microvascular complications in all diabetes types.
  • Management of blood pressure and lipids in type 2 diabetes patients significantly lowers cardiovascular morbidity and mortality.
  • Insulin therapy demonstrates beneficial effects on endothelial function and lipid profiles compared to sulfonylureas.

Conclusions:

  • While tight glycemic control aids microvascular health, its impact on macrovascular complications in type 2 diabetes requires further investigation.
  • Comprehensive management of insulin resistance factors is vital for cardiovascular risk reduction in type 2 diabetes.
  • Additional research is needed to fully elucidate the cardiovascular effects of various diabetes pharmacotherapies.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

An In Ovo Model for Testing Insulin-mimetic Compounds06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...